Selected research
Market Structure
Global Olanzapine Orally Disintegrating Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Olanzapine Orally Disintegrating Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Olanzapine Orally Disintegrating Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Olanzapine Orally Disintegrating Tablets include Apotex, Dr. Reddy's Laboratories, PKU HealthCare, QILU Pharmaceutical, Sunshine Lake Pharma, Torrent Pharmaceuticals, Eli Lilly Nederland B.V., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Olanzapine Orally Disintegrating Tablets market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Olanzapine Orally Disintegrating Tablets and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Olanzapine Orally Disintegrating Tablets revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Olanzapine Orally Disintegrating Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Olanzapine Orally Disintegrating Tablets Segment by Company
Apotex
Dr. Reddy's Laboratories
PKU HealthCare
QILU Pharmaceutical
Sunshine Lake Pharma
Torrent Pharmaceuticals
Eli Lilly Nederland B.V.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical
Chengdu Easton Biopharmaceuticals
Olanzapine Orally Disintegrating Tablets Segment by Type
5mg
20mg
15mg
10mg
Olanzapine Orally Disintegrating Tablets Segment by Application
Hospital
Clinic
Others
Olanzapine Orally Disintegrating Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine Orally Disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Olanzapine Orally Disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine Orally Disintegrating Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Olanzapine Orally Disintegrating Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Olanzapine Orally Disintegrating Tablets industry.
Chapter 3: Detailed analysis of Olanzapine Orally Disintegrating Tablets companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olanzapine Orally Disintegrating Tabletsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 20mg
- 15mg
- 10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Apotex
- Dr. Reddy's Laboratories
- PKU HealthCare
- QILU Pharmaceutical
- Sunshine Lake Pharma
- Torrent Pharmaceuticals
- Eli Lilly Nederland B.V.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical
- Chengdu Easton Biopharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 5mg
- 1.2.3 20mg
- 1.2.4 15mg
- 1.2.5 10mg
- 1.3 Market Analysis by Application
- 1.3.1 Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Olanzapine Orally Disintegrating Tablets Growth Trends by Region
- 1.5.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026)
- 1.5.3 Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Olanzapine Orally Disintegrating Tablets Market Dynamics
- 2.1 Olanzapine Orally Disintegrating Tablets Industry Trends
- 2.2 Olanzapine Orally Disintegrating Tablets Industry Drivers
- 2.3 Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges
- 2.4 Olanzapine Orally Disintegrating Tablets Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Company (2021-2026)
- 3.2 Global Olanzapine Orally Disintegrating Tablets Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Olanzapine Orally Disintegrating Tablets Key Company Head office and Area Served
- 3.4 Global Olanzapine Orally Disintegrating Tablets Company, Product Type & Application
- 3.5 Global Olanzapine Orally Disintegrating Tablets Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Olanzapine Orally Disintegrating Tablets Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Olanzapine Orally Disintegrating Tablets Players Market Share by Revenue in 2025
- 3.6.3 2025 Olanzapine Orally Disintegrating Tablets Tier 1, Tier 2, and Tier 3
4 Olanzapine Orally Disintegrating Tablets Market by Type
- 4.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2032)
- 4.3 Global Olanzapine Orally Disintegrating Tablets Market Size Share by Type (2021-2032)
5 Olanzapine Orally Disintegrating Tablets Market by Application
- 5.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2032)
- 5.3 Global Olanzapine Orally Disintegrating Tablets Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Apotex
- 6.1.1 Apotex Company Information
- 6.1.2 Apotex Business Overview
- 6.1.3 Apotex Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.1.5 Apotex Recent Developments
- 6.2 Dr. Reddy's Laboratories
- 6.2.1 Dr. Reddy's Laboratories Company Information
- 6.2.2 Dr. Reddy's Laboratories Business Overview
- 6.2.3 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.2.5 Dr. Reddy's Laboratories Recent Developments
- 6.3 PKU HealthCare
- 6.3.1 PKU HealthCare Company Information
- 6.3.2 PKU HealthCare Business Overview
- 6.3.3 PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.3.5 PKU HealthCare Recent Developments
- 6.4 QILU Pharmaceutical
- 6.4.1 QILU Pharmaceutical Company Information
- 6.4.2 QILU Pharmaceutical Business Overview
- 6.4.3 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.4.5 QILU Pharmaceutical Recent Developments
- 6.5 Sunshine Lake Pharma
- 6.5.1 Sunshine Lake Pharma Company Information
- 6.5.2 Sunshine Lake Pharma Business Overview
- 6.5.3 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.5.5 Sunshine Lake Pharma Recent Developments
- 6.6 Torrent Pharmaceuticals
- 6.6.1 Torrent Pharmaceuticals Company Information
- 6.6.2 Torrent Pharmaceuticals Business Overview
- 6.6.3 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.6.5 Torrent Pharmaceuticals Recent Developments
- 6.7 Eli Lilly Nederland B.V.
- 6.7.1 Eli Lilly Nederland B.V. Company Information
- 6.7.2 Eli Lilly Nederland B.V. Business Overview
- 6.7.3 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.7.5 Eli Lilly Nederland B.V. Recent Developments
- 6.8 Sun Pharmaceutical Industries Ltd.
- 6.8.1 Sun Pharmaceutical Industries Ltd. Company Information
- 6.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 6.8.3 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 6.9 Teva Pharmaceutical
- 6.9.1 Teva Pharmaceutical Company Information
- 6.9.2 Teva Pharmaceutical Business Overview
- 6.9.3 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.9.5 Teva Pharmaceutical Recent Developments
- 6.10 Chengdu Easton Biopharmaceuticals
- 6.10.1 Chengdu Easton Biopharmaceuticals Company Information
- 6.10.2 Chengdu Easton Biopharmaceuticals Business Overview
- 6.10.3 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
- 6.10.5 Chengdu Easton Biopharmaceuticals Recent Developments
7 North America
- 7.1 North America Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 7.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Type
- 7.2.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
- 7.2.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
- 7.2.3 North America Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
- 7.3 North America Olanzapine Orally Disintegrating Tablets Market Size by Application
- 7.3.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
- 7.3.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
- 7.3.3 North America Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
- 7.4 North America Olanzapine Orally Disintegrating Tablets Market Size by Country
- 7.4.1 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 7.4.3 North America Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 7.4.4 North America Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 8.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type
- 8.2.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
- 8.2.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
- 8.2.3 Europe Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
- 8.3 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application
- 8.3.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
- 8.3.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
- 8.3.3 Europe Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
- 8.4 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country
- 8.4.1 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 8.4.3 Europe Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 8.4.4 Europe Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 9.2 China Olanzapine Orally Disintegrating Tablets Market Size by Type
- 9.2.1 China Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
- 9.2.2 China Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
- 9.2.3 China Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
- 9.3 China Olanzapine Orally Disintegrating Tablets Market Size by Application
- 9.3.1 China Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
- 9.3.2 China Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
- 9.3.3 China Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 10.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type
- 10.2.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
- 10.2.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
- 10.2.3 Asia Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
- 10.3 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application
- 10.3.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
- 10.3.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
- 10.3.3 Asia Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
- 10.4 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country
- 10.4.1 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 10.4.3 Asia Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 10.4.4 Asia Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type
- 11.2.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application
- 11.3.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country
- 11.4.1 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Olanzapine Orally Disintegrating Tablets Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst